Skip to main content

Department of Pediatrics

We are committed to giving children a bright future. We provide the highest-quality clinical care, and we improve it every day through scientific research and training tomorrow's pediatrics leaders.

About Us

Welcome! For over a century, faculty at Emory University have provided clinical care to children in Georgia. The Department of Pediatrics is committed to providing the best clinical care, cutting-edge research, and training opportunities for tomorrow's pediatric leaders.

 

Jain with baby

Clinical Care

From rare diseases to routine procedures, we provide advanced treatment for children and teens through our clinical facilities at Children's Healthcare of Atlanta

Clinical Care

Leading the way in pediatric health

# 3 in NIH funding

We rank among the top pediatrics departments in the U.S. for National Institutes of Health funding awards.

5 Specialties in Top 10: U.S. News & World Report 2019-20

Nephrology, Gastroenterology & GI Surgery, Cancer, Orthopedics, and Urology ranked in the top 10 for USNWR.

73 children cured of sickle cell

The largest sickle cell program in the nation gives children suffering from the disease a healthy new future.

400+ clinical trials for pediatric cancer

Our Aflac Cancer and Blood Disorders Center has one of the largest brain tumor and leukemia-lymphoma programs in the U.S.

News Feature Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2 Evan Anderson, MD

Most reverse transcription PCR protocols for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) include 2–3 targets for detection. Researchers developed a triplex, real-time reverse transcription PCR for SARS-CoV-2 that maintained clinical performance compared with singleplex assays. This protocol could streamline detection and decrease reagent use during current high SARS-CoV-2 testing demands.

News Feature Remdesivir for the Treatment of Covid-19

A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in December 2019 as the cause of a respiratory illness designated coronavirus disease 2019, or Covid-19.1 Several therapeutic agents have been evaluated for the treatment of Covid-19, but none have yet been shown to be efficacious.

News feature Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease

Population-based rates of laboratory-confirmed coronavirus disease 2019 (COVID-19)–associated hospitalizations are lacking in the United States.

Pediatrics News

Loading News...

Events

Loading Events...